img

Global Lung Disease Therapeutic Drug Market Research Report 2024

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Lung Disease Therapeutic Drug Market Research Report 2024

According to Mr Accuracy reports’s new survey, global Lung Disease Therapeutic Drug market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Lung Disease Therapeutic Drug market research.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Lung Disease Therapeutic Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.



By Company


GSK
AstraZeneca
Boehringer Ingelheim
Novartis
Mylan
Vertex Pharmaceuticals
F. Hoffman La Roche
Teva Pharmaceuticals
Cipla
Fibrogen
Liminal Biosciences
PharmAkea Therapeutics
IQVIA
Segment by Type
Corticosteroids
Bronchodilator Medications
Mucolytics
Antimicrobial Medications
Others

Segment by Application


Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Consumption by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Lung Disease Therapeutic Drug report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source

Table of Content

1 Lung Disease Therapeutic Drug Market Overview
1.1 Product Overview and Scope of Lung Disease Therapeutic Drug
1.2 Lung Disease Therapeutic Drug Segment by Type
1.2.1 Global Lung Disease Therapeutic Drug Market Value Comparison by Type (2024-2034)
1.2.2 Corticosteroids
1.2.3 Bronchodilator Medications
1.2.4 Mucolytics
1.2.5 Antimicrobial Medications
1.2.6 Others
1.3 Lung Disease Therapeutic Drug Segment by Application
1.3.1 Global Lung Disease Therapeutic Drug Market Value by Application: (2024-2034)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Lung Disease Therapeutic Drug Market Size Estimates and Forecasts
1.4.1 Global Lung Disease Therapeutic Drug Revenue 2018-2029
1.4.2 Global Lung Disease Therapeutic Drug Sales 2018-2029
1.4.3 Global Lung Disease Therapeutic Drug Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Lung Disease Therapeutic Drug Market Competition by Manufacturers
2.1 Global Lung Disease Therapeutic Drug Sales Market Share by Manufacturers (2018-2024)
2.2 Global Lung Disease Therapeutic Drug Revenue Market Share by Manufacturers (2018-2024)
2.3 Global Lung Disease Therapeutic Drug Average Price by Manufacturers (2018-2024)
2.4 Global Lung Disease Therapeutic Drug Industry Ranking 2021 VS 2022 VS 2024
2.5 Global Key Manufacturers of Lung Disease Therapeutic Drug, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Lung Disease Therapeutic Drug, Product Type & Application
2.7 Lung Disease Therapeutic Drug Market Competitive Situation and Trends
2.7.1 Lung Disease Therapeutic Drug Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Lung Disease Therapeutic Drug Players Market Share by Revenue
2.7.3 Global Lung Disease Therapeutic Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Lung Disease Therapeutic Drug Retrospective Market Scenario by Region
3.1 Global Lung Disease Therapeutic Drug Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Lung Disease Therapeutic Drug Global Lung Disease Therapeutic Drug Sales by Region: 2018-2029
3.2.1 Global Lung Disease Therapeutic Drug Sales by Region: 2018-2024
3.2.2 Global Lung Disease Therapeutic Drug Sales by Region: 2024-2029
3.3 Global Lung Disease Therapeutic Drug Global Lung Disease Therapeutic Drug Revenue by Region: 2018-2029
3.3.1 Global Lung Disease Therapeutic Drug Revenue by Region: 2018-2024
3.3.2 Global Lung Disease Therapeutic Drug Revenue by Region: 2024-2029
3.4 North America Lung Disease Therapeutic Drug Market Facts & Figures by Country
3.4.1 North America Lung Disease Therapeutic Drug Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Lung Disease Therapeutic Drug Sales by Country (2018-2029)
3.4.3 North America Lung Disease Therapeutic Drug Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Lung Disease Therapeutic Drug Market Facts & Figures by Country
3.5.1 Europe Lung Disease Therapeutic Drug Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Lung Disease Therapeutic Drug Sales by Country (2018-2029)
3.5.3 Europe Lung Disease Therapeutic Drug Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Lung Disease Therapeutic Drug Market Facts & Figures by Country
3.6.1 Asia Pacific Lung Disease Therapeutic Drug Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Lung Disease Therapeutic Drug Sales by Country (2018-2029)
3.6.3 Asia Pacific Lung Disease Therapeutic Drug Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Lung Disease Therapeutic Drug Market Facts & Figures by Country
3.7.1 Latin America Lung Disease Therapeutic Drug Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Lung Disease Therapeutic Drug Sales by Country (2018-2029)
3.7.3 Latin America Lung Disease Therapeutic Drug Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Lung Disease Therapeutic Drug Market Facts & Figures by Country
3.8.1 Middle East and Africa Lung Disease Therapeutic Drug Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Lung Disease Therapeutic Drug Sales by Country (2018-2029)
3.8.3 Middle East and Africa Lung Disease Therapeutic Drug Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Lung Disease Therapeutic Drug Sales by Type (2018-2029)
4.1.1 Global Lung Disease Therapeutic Drug Sales by Type (2018-2024)
4.1.2 Global Lung Disease Therapeutic Drug Sales by Type (2024-2029)
4.1.3 Global Lung Disease Therapeutic Drug Sales Market Share by Type (2018-2029)
4.2 Global Lung Disease Therapeutic Drug Revenue by Type (2018-2029)
4.2.1 Global Lung Disease Therapeutic Drug Revenue by Type (2018-2024)
4.2.2 Global Lung Disease Therapeutic Drug Revenue by Type (2024-2029)
4.2.3 Global Lung Disease Therapeutic Drug Revenue Market Share by Type (2018-2029)
4.3 Global Lung Disease Therapeutic Drug Price by Type (2018-2029)
5 Segment by Application
5.1 Global Lung Disease Therapeutic Drug Sales by Application (2018-2029)
5.1.1 Global Lung Disease Therapeutic Drug Sales by Application (2018-2024)
5.1.2 Global Lung Disease Therapeutic Drug Sales by Application (2024-2029)
5.1.3 Global Lung Disease Therapeutic Drug Sales Market Share by Application (2018-2029)
5.2 Global Lung Disease Therapeutic Drug Revenue by Application (2018-2029)
5.2.1 Global Lung Disease Therapeutic Drug Revenue by Application (2018-2024)
5.2.2 Global Lung Disease Therapeutic Drug Revenue by Application (2024-2029)
5.2.3 Global Lung Disease Therapeutic Drug Revenue Market Share by Application (2018-2029)
5.3 Global Lung Disease Therapeutic Drug Price by Application (2018-2029)
6 Key Companies Profiled
6.1 GSK
6.1.1 GSK Corporation Information
6.1.2 GSK Description and Business Overview
6.1.3 GSK Lung Disease Therapeutic Drug Sales, Revenue and Gross Margin (2018-2024)
6.1.4 GSK Lung Disease Therapeutic Drug Product Portfolio
6.1.5 GSK Recent Developments/Updates
6.2 AstraZeneca
6.2.1 AstraZeneca Corporation Information
6.2.2 AstraZeneca Description and Business Overview
6.2.3 AstraZeneca Lung Disease Therapeutic Drug Sales, Revenue and Gross Margin (2018-2024)
6.2.4 AstraZeneca Lung Disease Therapeutic Drug Product Portfolio
6.2.5 AstraZeneca Recent Developments/Updates
6.3 Boehringer Ingelheim
6.3.1 Boehringer Ingelheim Corporation Information
6.3.2 Boehringer Ingelheim Description and Business Overview
6.3.3 Boehringer Ingelheim Lung Disease Therapeutic Drug Sales, Revenue and Gross Margin (2018-2024)
6.3.4 Boehringer Ingelheim Lung Disease Therapeutic Drug Product Portfolio
6.3.5 Boehringer Ingelheim Recent Developments/Updates
6.4 Novartis
6.4.1 Novartis Corporation Information
6.4.2 Novartis Description and Business Overview
6.4.3 Novartis Lung Disease Therapeutic Drug Sales, Revenue and Gross Margin (2018-2024)
6.4.4 Novartis Lung Disease Therapeutic Drug Product Portfolio
6.4.5 Novartis Recent Developments/Updates
6.5 Mylan
6.5.1 Mylan Corporation Information
6.5.2 Mylan Description and Business Overview
6.5.3 Mylan Lung Disease Therapeutic Drug Sales, Revenue and Gross Margin (2018-2024)
6.5.4 Mylan Lung Disease Therapeutic Drug Product Portfolio
6.5.5 Mylan Recent Developments/Updates
6.6 Vertex Pharmaceuticals
6.6.1 Vertex Pharmaceuticals Corporation Information
6.6.2 Vertex Pharmaceuticals Description and Business Overview
6.6.3 Vertex Pharmaceuticals Lung Disease Therapeutic Drug Sales, Revenue and Gross Margin (2018-2024)
6.6.4 Vertex Pharmaceuticals Lung Disease Therapeutic Drug Product Portfolio
6.6.5 Vertex Pharmaceuticals Recent Developments/Updates
6.7 F. Hoffman La Roche
6.6.1 F. Hoffman La Roche Corporation Information
6.6.2 F. Hoffman La Roche Description and Business Overview
6.6.3 F. Hoffman La Roche Lung Disease Therapeutic Drug Sales, Revenue and Gross Margin (2018-2024)
6.4.4 F. Hoffman La Roche Lung Disease Therapeutic Drug Product Portfolio
6.7.5 F. Hoffman La Roche Recent Developments/Updates
6.8 Teva Pharmaceuticals
6.8.1 Teva Pharmaceuticals Corporation Information
6.8.2 Teva Pharmaceuticals Description and Business Overview
6.8.3 Teva Pharmaceuticals Lung Disease Therapeutic Drug Sales, Revenue and Gross Margin (2018-2024)
6.8.4 Teva Pharmaceuticals Lung Disease Therapeutic Drug Product Portfolio
6.8.5 Teva Pharmaceuticals Recent Developments/Updates
6.9 Cipla
6.9.1 Cipla Corporation Information
6.9.2 Cipla Description and Business Overview
6.9.3 Cipla Lung Disease Therapeutic Drug Sales, Revenue and Gross Margin (2018-2024)
6.9.4 Cipla Lung Disease Therapeutic Drug Product Portfolio
6.9.5 Cipla Recent Developments/Updates
6.10 Fibrogen
6.10.1 Fibrogen Corporation Information
6.10.2 Fibrogen Description and Business Overview
6.10.3 Fibrogen Lung Disease Therapeutic Drug Sales, Revenue and Gross Margin (2018-2024)
6.10.4 Fibrogen Lung Disease Therapeutic Drug Product Portfolio
6.10.5 Fibrogen Recent Developments/Updates
6.11 Liminal Biosciences
6.11.1 Liminal Biosciences Corporation Information
6.11.2 Liminal Biosciences Lung Disease Therapeutic Drug Description and Business Overview
6.11.3 Liminal Biosciences Lung Disease Therapeutic Drug Sales, Revenue and Gross Margin (2018-2024)
6.11.4 Liminal Biosciences Lung Disease Therapeutic Drug Product Portfolio
6.11.5 Liminal Biosciences Recent Developments/Updates
6.12 PharmAkea Therapeutics
6.12.1 PharmAkea Therapeutics Corporation Information
6.12.2 PharmAkea Therapeutics Lung Disease Therapeutic Drug Description and Business Overview
6.12.3 PharmAkea Therapeutics Lung Disease Therapeutic Drug Sales, Revenue and Gross Margin (2018-2024)
6.12.4 PharmAkea Therapeutics Lung Disease Therapeutic Drug Product Portfolio
6.12.5 PharmAkea Therapeutics Recent Developments/Updates
6.13 IQVIA
6.13.1 IQVIA Corporation Information
6.13.2 IQVIA Lung Disease Therapeutic Drug Description and Business Overview
6.13.3 IQVIA Lung Disease Therapeutic Drug Sales, Revenue and Gross Margin (2018-2024)
6.13.4 IQVIA Lung Disease Therapeutic Drug Product Portfolio
6.13.5 IQVIA Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Lung Disease Therapeutic Drug Industry Chain Analysis
7.2 Lung Disease Therapeutic Drug Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Lung Disease Therapeutic Drug Production Mode & Process
7.4 Lung Disease Therapeutic Drug Sales and Marketing
7.4.1 Lung Disease Therapeutic Drug Sales Channels
7.4.2 Lung Disease Therapeutic Drug Distributors
7.5 Lung Disease Therapeutic Drug Customers
8 Lung Disease Therapeutic Drug Market Dynamics
8.1 Lung Disease Therapeutic Drug Industry Trends
8.2 Lung Disease Therapeutic Drug Market Drivers
8.3 Lung Disease Therapeutic Drug Market Challenges
8.4 Lung Disease Therapeutic Drug Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Lung Disease Therapeutic Drug Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Lung Disease Therapeutic Drug Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Lung Disease Therapeutic Drug Market Competitive Situation by Manufacturers in 2022
Table 4. Global Lung Disease Therapeutic Drug Sales (K Units) of Key Manufacturers (2018-2024)
Table 5. Global Lung Disease Therapeutic Drug Sales Market Share by Manufacturers (2018-2024)
Table 6. Global Lung Disease Therapeutic Drug Revenue (US$ Million) by Manufacturers (2018-2024)
Table 7. Global Lung Disease Therapeutic Drug Revenue Share by Manufacturers (2018-2024)
Table 8. Global Market Lung Disease Therapeutic Drug Average Price (US$/Unit) of Key Manufacturers (2018-2024)
Table 9. Global Key Players of Lung Disease Therapeutic Drug, Industry Ranking, 2021 VS 2022 VS 2024
Table 10. Global Key Manufacturers of Lung Disease Therapeutic Drug, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Lung Disease Therapeutic Drug, Product Type & Application
Table 12. Global Key Manufacturers of Lung Disease Therapeutic Drug, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Lung Disease Therapeutic Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Disease Therapeutic Drug as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Lung Disease Therapeutic Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Lung Disease Therapeutic Drug Sales by Region (2018-2024) & (K Units)
Table 18. Global Lung Disease Therapeutic Drug Sales Market Share by Region (2018-2024)
Table 19. Global Lung Disease Therapeutic Drug Sales by Region (2024-2029) & (K Units)
Table 20. Global Lung Disease Therapeutic Drug Sales Market Share by Region (2024-2029)
Table 21. Global Lung Disease Therapeutic Drug Revenue by Region (2018-2024) & (US$ Million)
Table 22. Global Lung Disease Therapeutic Drug Revenue Market Share by Region (2018-2024)
Table 23. Global Lung Disease Therapeutic Drug Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Lung Disease Therapeutic Drug Revenue Market Share by Region (2024-2029)
Table 25. North America Lung Disease Therapeutic Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Lung Disease Therapeutic Drug Sales by Country (2018-2024) & (K Units)
Table 27. North America Lung Disease Therapeutic Drug Sales by Country (2024-2029) & (K Units)
Table 28. North America Lung Disease Therapeutic Drug Revenue by Country (2018-2024) & (US$ Million)
Table 29. North America Lung Disease Therapeutic Drug Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Lung Disease Therapeutic Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Lung Disease Therapeutic Drug Sales by Country (2018-2024) & (K Units)
Table 32. Europe Lung Disease Therapeutic Drug Sales by Country (2024-2029) & (K Units)
Table 33. Europe Lung Disease Therapeutic Drug Revenue by Country (2018-2024) & (US$ Million)
Table 34. Europe Lung Disease Therapeutic Drug Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Lung Disease Therapeutic Drug Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Lung Disease Therapeutic Drug Sales by Region (2018-2024) & (K Units)
Table 37. Asia Pacific Lung Disease Therapeutic Drug Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Lung Disease Therapeutic Drug Revenue by Region (2018-2024) & (US$ Million)
Table 39. Asia Pacific Lung Disease Therapeutic Drug Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Lung Disease Therapeutic Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Lung Disease Therapeutic Drug Sales by Country (2018-2024) & (K Units)
Table 42. Latin America Lung Disease Therapeutic Drug Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Lung Disease Therapeutic Drug Revenue by Country (2018-2024) & (US$ Million)
Table 44. Latin America Lung Disease Therapeutic Drug Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Lung Disease Therapeutic Drug Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Lung Disease Therapeutic Drug Sales by Country (2018-2024) & (K Units)
Table 47. Middle East & Africa Lung Disease Therapeutic Drug Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Lung Disease Therapeutic Drug Revenue by Country (2018-2024) & (US$ Million)
Table 49. Middle East & Africa Lung Disease Therapeutic Drug Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Lung Disease Therapeutic Drug Sales (K Units) by Type (2018-2024)
Table 51. Global Lung Disease Therapeutic Drug Sales (K Units) by Type (2024-2029)
Table 52. Global Lung Disease Therapeutic Drug Sales Market Share by Type (2018-2024)
Table 53. Global Lung Disease Therapeutic Drug Sales Market Share by Type (2024-2029)
Table 54. Global Lung Disease Therapeutic Drug Revenue (US$ Million) by Type (2018-2024)
Table 55. Global Lung Disease Therapeutic Drug Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Lung Disease Therapeutic Drug Revenue Market Share by Type (2018-2024)
Table 57. Global Lung Disease Therapeutic Drug Revenue Market Share by Type (2024-2029)
Table 58. Global Lung Disease Therapeutic Drug Price (US$/Unit) by Type (2018-2024)
Table 59. Global Lung Disease Therapeutic Drug Price (US$/Unit) by Type (2024-2029)
Table 60. Global Lung Disease Therapeutic Drug Sales (K Units) by Application (2018-2024)
Table 61. Global Lung Disease Therapeutic Drug Sales (K Units) by Application (2024-2029)
Table 62. Global Lung Disease Therapeutic Drug Sales Market Share by Application (2018-2024)
Table 63. Global Lung Disease Therapeutic Drug Sales Market Share by Application (2024-2029)
Table 64. Global Lung Disease Therapeutic Drug Revenue (US$ Million) by Application (2018-2024)
Table 65. Global Lung Disease Therapeutic Drug Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Lung Disease Therapeutic Drug Revenue Market Share by Application (2018-2024)
Table 67. Global Lung Disease Therapeutic Drug Revenue Market Share by Application (2024-2029)
Table 68. Global Lung Disease Therapeutic Drug Price (US$/Unit) by Application (2018-2024)
Table 69. Global Lung Disease Therapeutic Drug Price (US$/Unit) by Application (2024-2029)
Table 70. GSK Corporation Information
Table 71. GSK Description and Business Overview
Table 72. GSK Lung Disease Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 73. GSK Lung Disease Therapeutic Drug Product
Table 74. GSK Recent Developments/Updates
Table 75. AstraZeneca Corporation Information
Table 76. AstraZeneca Description and Business Overview
Table 77. AstraZeneca Lung Disease Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 78. AstraZeneca Lung Disease Therapeutic Drug Product
Table 79. AstraZeneca Recent Developments/Updates
Table 80. Boehringer Ingelheim Corporation Information
Table 81. Boehringer Ingelheim Description and Business Overview
Table 82. Boehringer Ingelheim Lung Disease Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 83. Boehringer Ingelheim Lung Disease Therapeutic Drug Product
Table 84. Boehringer Ingelheim Recent Developments/Updates
Table 85. Novartis Corporation Information
Table 86. Novartis Description and Business Overview
Table 87. Novartis Lung Disease Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 88. Novartis Lung Disease Therapeutic Drug Product
Table 89. Novartis Recent Developments/Updates
Table 90. Mylan Corporation Information
Table 91. Mylan Description and Business Overview
Table 92. Mylan Lung Disease Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 93. Mylan Lung Disease Therapeutic Drug Product
Table 94. Mylan Recent Developments/Updates
Table 95. Vertex Pharmaceuticals Corporation Information
Table 96. Vertex Pharmaceuticals Description and Business Overview
Table 97. Vertex Pharmaceuticals Lung Disease Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 98. Vertex Pharmaceuticals Lung Disease Therapeutic Drug Product
Table 99. Vertex Pharmaceuticals Recent Developments/Updates
Table 100. F. Hoffman La Roche Corporation Information
Table 101. F. Hoffman La Roche Description and Business Overview
Table 102. F. Hoffman La Roche Lung Disease Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 103. F. Hoffman La Roche Lung Disease Therapeutic Drug Product
Table 104. F. Hoffman La Roche Recent Developments/Updates
Table 105. Teva Pharmaceuticals Corporation Information
Table 106. Teva Pharmaceuticals Description and Business Overview
Table 107. Teva Pharmaceuticals Lung Disease Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 108. Teva Pharmaceuticals Lung Disease Therapeutic Drug Product
Table 109. Teva Pharmaceuticals Recent Developments/Updates
Table 110. Cipla Corporation Information
Table 111. Cipla Description and Business Overview
Table 112. Cipla Lung Disease Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 113. Cipla Lung Disease Therapeutic Drug Product
Table 114. Cipla Recent Developments/Updates
Table 115. Fibrogen Corporation Information
Table 116. Fibrogen Description and Business Overview
Table 117. Fibrogen Lung Disease Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 118. Fibrogen Lung Disease Therapeutic Drug Product
Table 119. Fibrogen Recent Developments/Updates
Table 120. Liminal Biosciences Corporation Information
Table 121. Liminal Biosciences Description and Business Overview
Table 122. Liminal Biosciences Lung Disease Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 123. Liminal Biosciences Lung Disease Therapeutic Drug Product
Table 124. Liminal Biosciences Recent Developments/Updates
Table 125. PharmAkea Therapeutics Corporation Information
Table 126. PharmAkea Therapeutics Description and Business Overview
Table 127. PharmAkea Therapeutics Lung Disease Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 128. PharmAkea Therapeutics Lung Disease Therapeutic Drug Product
Table 129. PharmAkea Therapeutics Recent Developments/Updates
Table 130. IQVIA Corporation Information
Table 131. IQVIA Description and Business Overview
Table 132. IQVIA Lung Disease Therapeutic Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 133. IQVIA Lung Disease Therapeutic Drug Product
Table 134. IQVIA Recent Developments/Updates
Table 135. Key Raw Materials Lists
Table 136. Raw Materials Key Suppliers Lists
Table 137. Lung Disease Therapeutic Drug Distributors List
Table 138. Lung Disease Therapeutic Drug Customers List
Table 139. Lung Disease Therapeutic Drug Market Trends
Table 140. Lung Disease Therapeutic Drug Market Drivers
Table 141. Lung Disease Therapeutic Drug Market Challenges
Table 142. Lung Disease Therapeutic Drug Market Restraints
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Lung Disease Therapeutic Drug
Figure 2. Global Lung Disease Therapeutic Drug Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Lung Disease Therapeutic Drug Market Share by Type in 2022 & 2029
Figure 4. Corticosteroids Product Picture
Figure 5. Bronchodilator Medications Product Picture
Figure 6. Mucolytics Product Picture
Figure 7. Antimicrobial Medications Product Picture
Figure 8. Others Product Picture
Figure 9. Global Lung Disease Therapeutic Drug Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 10. Global Lung Disease Therapeutic Drug Market Share by Application in 2022 & 2029
Figure 11. Hospital Pharmacies
Figure 12. Retail Pharmacies
Figure 13. Online Pharmacies
Figure 14. Global Lung Disease Therapeutic Drug Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 15. Global Lung Disease Therapeutic Drug Market Size (2018-2029) & (US$ Million)
Figure 16. Global Lung Disease Therapeutic Drug Sales (2018-2029) & (K Units)
Figure 17. Global Lung Disease Therapeutic Drug Average Price (US$/Unit) & (2018-2029)
Figure 18. Lung Disease Therapeutic Drug Report Years Considered
Figure 19. Lung Disease Therapeutic Drug Sales Share by Manufacturers in 2022
Figure 20. Global Lung Disease Therapeutic Drug Revenue Share by Manufacturers in 2022
Figure 21. The Global 5 and 10 Largest Lung Disease Therapeutic Drug Players: Market Share by Revenue in 2022
Figure 22. Lung Disease Therapeutic Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 23. Global Lung Disease Therapeutic Drug Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 24. North America Lung Disease Therapeutic Drug Sales Market Share by Country (2018-2029)
Figure 25. North America Lung Disease Therapeutic Drug Revenue Market Share by Country (2018-2029)
Figure 26. United States Lung Disease Therapeutic Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 27. Canada Lung Disease Therapeutic Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. Europe Lung Disease Therapeutic Drug Sales Market Share by Country (2018-2029)
Figure 29. Europe Lung Disease Therapeutic Drug Revenue Market Share by Country (2018-2029)
Figure 30. Germany Lung Disease Therapeutic Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. France Lung Disease Therapeutic Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. U.K. Lung Disease Therapeutic Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Italy Lung Disease Therapeutic Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 34. Russia Lung Disease Therapeutic Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Asia Pacific Lung Disease Therapeutic Drug Sales Market Share by Region (2018-2029)
Figure 36. Asia Pacific Lung Disease Therapeutic Drug Revenue Market Share by Region (2018-2029)
Figure 37. China Lung Disease Therapeutic Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Japan Lung Disease Therapeutic Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. South Korea Lung Disease Therapeutic Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. India Lung Disease Therapeutic Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Australia Lung Disease Therapeutic Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. China Taiwan Lung Disease Therapeutic Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Southeast Asia Lung Disease Therapeutic Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Latin America Lung Disease Therapeutic Drug Sales Market Share by Country (2018-2029)
Figure 45. Latin America Lung Disease Therapeutic Drug Revenue Market Share by Country (2018-2029)
Figure 46. Mexico Lung Disease Therapeutic Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Brazil Lung Disease Therapeutic Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Argentina Lung Disease Therapeutic Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Middle East & Africa Lung Disease Therapeutic Drug Sales Market Share by Country (2018-2029)
Figure 50. Middle East & Africa Lung Disease Therapeutic Drug Revenue Market Share by Country (2018-2029)
Figure 51. Turkey Lung Disease Therapeutic Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Saudi Arabia Lung Disease Therapeutic Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. UAE Lung Disease Therapeutic Drug Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Global Sales Market Share of Lung Disease Therapeutic Drug by Type (2018-2029)
Figure 55. Global Revenue Market Share of Lung Disease Therapeutic Drug by Type (2018-2029)
Figure 56. Global Lung Disease Therapeutic Drug Price (US$/Unit) by Type (2018-2029)
Figure 57. Global Sales Market Share of Lung Disease Therapeutic Drug by Application (2018-2029)
Figure 58. Global Revenue Market Share of Lung Disease Therapeutic Drug by Application (2018-2029)
Figure 59. Global Lung Disease Therapeutic Drug Price (US$/Unit) by Application (2018-2029)
Figure 60. Lung Disease Therapeutic Drug Value Chain
Figure 61. Lung Disease Therapeutic Drug Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries